Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

PHASE1UnknownINTERVENTIONAL
Timeline

Start Date

February 28, 2002

Conditions
Lymphoma
Interventions
DRUG

cisplatin

DRUG

cytarabine

DRUG

methylprednisolone

DRUG

pixantrone dimaleate

Trial Locations (7)

21201

Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

38104

Boston Baskin Cancer Group, University Tennessee, Memphis

72764

Highlands Oncology Group, Springdale

77030

University of Texas - MD Anderson Cancer Center, Houston

85712

Arizona Clinical Research Center, Tucson

90033-0800

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

44106-5055

Ireland Cancer Center, Cleveland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theradex

INDUSTRY